BIOLINQ SOL Trademark

Trademark Overview

On Thursday, January 20, 2022, a trademark application was filed for BIOLINQ SOL with the United States Patent and Trademark Office. The USPTO has given the BIOLINQ SOL trademark a serial number of 97229414. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Biolinq Incorporated. The BIOLINQ SOL trademark is filed in the Medical Instrument Products category with the following description:

Wearable monitors used to measure biometric data for medical use; glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose levels for medical purposes
biolinq sol

General Information

Serial Number97229414
Word MarkBIOLINQ SOL
Filing DateThursday, January 20, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Translation of Words in MarkThe English translation of the word "SOL" in the mark is "SUN".
Goods and ServicesWearable monitors used to measure biometric data for medical use; glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose levels for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiolinq Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBiolinq Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, November 3, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, January 24, 2022NEW APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 31, 2022ASSIGNED TO EXAMINER
Thursday, November 3, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, November 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 22, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 17, 2023ASSIGNED TO PETITION STAFF
Monday, January 23, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2023SOU EXTENSION 1 FILED
Monday, August 7, 2023SOU EXTENSION 1 GRANTED
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 2 FILED
Wednesday, January 24, 2024SOU EXTENSION 2 GRANTED

Related Keywords

biolinq glucose medical wearable continuous sensors monitoring purposes levels blood namely